Literature DB >> 9151815

Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells.

B M Dutia1, C J Clarke, D J Allen, A A Nash.   

Abstract

Murine gammaherpesvirus is a natural rodent pathogen which causes a primary infection in the lungs and establishes a persistent infection in B lymphocytes. During the primary infection, large amounts of gamma interferon (IFN-gamma) are produced by spleen, mediastinal, and cervical lymph node cells. To investigate the role of IFN-gamma in control of the virus infection, mice lacking the cellular receptor for IFN-gamma (IFN-gamma R-/- mice) were infected with murine gammaherpesvirus 68 (MHV68). IFN-gamma R-/- mice showed no difference from wild-type mice in the titers of infectious virus in the lungs or in the rate of clearance of the lung infection. In the spleen, however, clear differences were observed. By 14 days postinfection, spleens from IFN-gamma R-/- mice were pale, shrunken, and fibrous. Histological examination showed that there was an early (day 10) infiltration of granulocytes followed by widespread destruction of splenic architecture (days 14 to 17). A marked decrease in the number of splenic B cells and CD4+ and CD8+ T cells occurred. These changes were accompanied by a 10- to 100-fold greater load of latently infected cells in IFN-gamma R-/- mice than in wild-type mice at 14 to 17 days postinfection, but this was reduced to the levels found in wild-type mice by 21 days postinfection. Treatment of the mice with the antiviral drug 2'-deoxyl-5-ethyl-beta-4'-thiouridine from 6 days postinfection did not prevent the occurrence of these changes. The changes were, however, completely reversed by depletion of CD8+ T cells prior to and during the primary infection. Depletion of CD4+ T cells also reversed the major pathological and virological changes, although in this case there was evidence of some histological changes. Thus, the lack of IFN-gamma receptor had profound consequences in spleens of MHV68-infected mice. The possible mechanisms involved in these changes are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151815      PMCID: PMC191643     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice.

Authors:  E J Usherwood; J P Stewart; K Robertson; D J Allen; A A Nash
Journal:  J Gen Virol       Date:  1996-11       Impact factor: 3.891

2.  Equine herpesviruses 2 and 5 are gamma-herpesviruses.

Authors:  E A Telford; M J Studdert; C T Agius; M S Watson; H C Aird; A J Davison
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

3.  Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.

Authors:  R D Cardin; J W Brooks; S R Sarawar; P C Doherty
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

4.  Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells.

Authors:  S Ehtisham; N P Sunil-Chandra; A A Nash
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

5.  IFN-gamma receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses.

Authors:  V E Schijns; B L Haagmans; E O Rijke; S Huang; M Aguet; M C Horzinek
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

6.  Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo.

Authors:  N P Sunil-Chandra; S Efstathiou; A A Nash
Journal:  J Gen Virol       Date:  1992-12       Impact factor: 3.891

7.  The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections.

Authors:  M T Heise; H W Virgin
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).

Authors:  P M Smith; R M Wolcott; R Chervenak; S R Jennings
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

9.  Effects of IL-12 on the response and susceptibility to experimental viral infections.

Authors:  J S Orange; S F Wolf; C A Biron
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

10.  Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

Authors:  W E Carson; J G Giri; M J Lindemann; M L Linett; M Ahdieh; R Paxton; D Anderson; J Eisenmann; K Grabstein; M A Caligiuri
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  49 in total

1.  CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma.

Authors:  J P Christensen; R D Cardin; K C Branum; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis.

Authors:  Victor van Berkel; Beth Levine; Sharookh B Kapadia; James E Goldman; Samuel H Speck; Herbert W Virgin
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

3.  Maintenance of gammaherpesvirus latency requires viral cyclin in the absence of B lymphocytes.

Authors:  Linda F van Dyk; Herbert W Virgin; Samuel H Speck
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency.

Authors:  James Scott McClellan; Scott A Tibbetts; Shivaprakash Gangappa; Kelly A Brett; Herbert W Virgin
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

5.  Strain-dependent requirement for IFN-γ for respiratory control and immunotherapy in murine gammaherpesvirus infection.

Authors:  Ching-Yi Tsai; Zhuting Hu; Weijun Zhang; Edward J Usherwood
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

6.  CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68.

Authors:  Shinichiro Fuse; Joshua J Obar; Sarah Bellfy; Erica K Leung; Weijun Zhang; Edward J Usherwood
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

7.  gamma-Herpesvirus-induced protection against bacterial infection is transient.

Authors:  Eric J Yager; Frank M Szaba; Larry W Kummer; Kathleen G Lanzer; Claire E Burkum; Stephen T Smiley; Marcia A Blackman
Journal:  Viral Immunol       Date:  2009-02       Impact factor: 2.257

8.  The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency.

Authors:  Kathleen S Gray; J Craig Forrest; Samuel H Speck
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

9.  LXR Alpha Restricts Gammaherpesvirus Reactivation from Latently Infected Peritoneal Cells.

Authors:  P T Lange; C N Jondle; E J Darrah; K E Johnson; V L Tarakanova
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

10.  Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice.

Authors:  H W Virgin; R M Presti; X Y Li; C Liu; S H Speck
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.